PI3K Signaling at the Crossroads of Lipid Metabolism and Cancer

Molecular mechanisms of PI3K isoform dependence in embryonic growth

Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt

Cholesterol biogenesis is a PTEN‐dependent actionable node for the treatment of endocrine therapy‐refractory cancers

Rafting on the Plasma Membrane: Lipid Rafts in Signaling and Disease

Blocking PI3K p110β attenuates development of PTEN-deficient castration-resistant prostate cancer

ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK-STAT3 Pathway

p110alpha activity at the M-to-G1 transition is critical for cellular proliferation and reentry into the cell cycle